Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, EpiSciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation
Conference papers

P18-11. DALIA: dendritic cell and lipopeptide-induced immunity against AIDS: a phase I trial

Jacques Banchereau 1 Carson Harrod 1, * Amanda Cobb 1 Geneviève Chêne 2 Louis Sloan 3 Karolina Palucka 1 yves Levy 4 
* Corresponding author
1 Développement de nouveaux vaccins pour le traitement de maladies virales chroniques
2 ISPED - Institut de Santé Publique, d'Epidémiologie et de Développement
3 North Texas Infectious Diseases Clinic
4 Agence Nationale de Recherche sur le Sida et les hépatites virales
Résumé : n.a
Document type :
Conference papers
Complete list of metadata
https://www.hal.inserm.fr/inserm-00663917
Contributor : Ed. BMC Connect in order to contact the contributor
Submitted on : Friday, January 27, 2012 - 5:19:55 PM
Last modification on : Wednesday, June 19, 2019 - 11:48:04 AM
Long-term archiving on: : Saturday, April 28, 2012 - 2:42:10 AM

Files

Vignette du document
1742-4690-6-S3-P320.pdf
Publisher files allowed on an open archive

Identifiers

Collections

INSERM

Citation

Jacques Banchereau, Carson Harrod, Amanda Cobb, Geneviève Chêne, Louis Sloan, et al.. P18-11. DALIA: dendritic cell and lipopeptide-induced immunity against AIDS: a phase I trial. AIDS Vaccine 2009, Oct 2009, Paris, France. pp.P320, ⟨10.1186/1742-4690-6-S3-P320⟩. ⟨inserm-00663917⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

61

Files downloads

123